Gadducci et al. also demonstrated increased VEGF-A immunostaining in peritoneal metastatic lesions of ovarian cancer, but without showing prognostic significance or relation to clinical outcome [28]. This evidence concerns the gene VEGFA and ovarian carcinoma.